美国2013-2019年药物与合成阿片类药物过量死亡趋势及地理分布
CDC分析2013-2019年美国药物过量死亡趋势及2018-2019年合成阿片类和兴奋剂类死亡地理分布。2019年药物过量死亡70,630例,年龄调整率21.6/10万,较2018年上升4.3%。合成阿片类相关死亡率2013-2019年上升1,040%,兴奋剂类上升317%;2018-2019年合成阿片类死亡率相对增幅最大在西部(67.9%),兴奋剂类最大在东北部(43.8%)。
要点
- 2019年美国药物过量死亡70,630例,年龄调整率21.6/10万,较2018年上升4.3%。
- 2013-2019年合成阿片类相关死亡率上升1,040%,从1.0升至11.4/10万。
- 2018-2019年合成阿片类死亡率相对增幅最大在西部(67.9%),兴奋剂类在东北部(43.8%)。
核心结论
- 药物过量死亡疫情持续演变,合成阿片类和兴奋剂类相关死亡大幅增加且地理分布发生变化。
- 需将基于证据的预防和应对策略(包括物质使用障碍治疗和针对多物质使用的过量预防与应对)适配于不断变化的疫情。
研究设计与样本
- CDC对2013-2019年年龄调整药物过量死亡率趋势进行分析,并分析2018-2019年合成阿片类和兴奋剂类相关死亡的地理分布。
- 分析涉及合成阿片类、兴奋剂类、可卡因、海洛因和处方阿片类药物相关死亡。
主要发现
- 2019年药物过量死亡70,630例,年龄调整率21.6/10万,较2018年率(20.7)上升4.3%。
- 2013-2019年合成阿片类相关死亡率上升1,040%,从1.0/10万(3,105例)升至11.4/10万(36,359例)。
- 2013-2019年兴奋剂类相关死亡率上升317%,从1.2/10万(3,627例)升至5.0/10万(16,167例)。
- 存在合成阿片类共同参与时,处方阿片类、海洛因、兴奋剂类和可卡因死亡率均上升;无合成阿片类共同参与时,仅兴奋剂类和可卡因死亡率上升。
- 2018-2019年合成阿片类相关死亡率相对增幅最大在西部(67.9%),兴奋剂类相关死亡率相对增幅最大在东北部(43.8%)。
临床怎么用
- 应关注合成阿片类和兴奋剂类共同参与的多物质使用模式,并据此调整过量预防与应对策略。
- 基于证据的预防和应对策略应包括物质使用障碍治疗以及针对多物质使用的过量预防和应对努力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deaths involving synthetic opioids other than methadone (synthetic opioids), which largely consist of illicitly manufactured fentanyl; psychostimulants with abuse potential (e.g., methamphetamine); and cocaine have increased in recent years, particularly since 2013 (1,2). In 2019, a total of 70,630 drug overdose deaths occurred, corresponding to an age-adjusted rate of 21.6 per 100,000 population and a 4.3% increase from the 2018 rate (20.7) (3). CDC analyzed trends in age-adjusted overdose death rates involving synthetic opioids, psychostimulants, cocaine, heroin, and prescription opioids during 2013-2019, as well as geographic patterns in synthetic opioid- and psychostimulant-involved deaths during 2018-2019. From 2013 to 2019, the synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4 per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0 (16,167) in 2019. In the presence of synthetic opioid coinvolvement, death rates for prescription opioids, heroin, psychostimulants, and cocaine increased. In the absence of synthetic opioid coinvolvement, death rates increased only for psychostimulants and cocaine. From 2018 to 2019, the largest relative increase in the synthetic opioid-involved death rate occurred in the West (67.9%), and the largest relative increase in the psychostimulant-involved death rate occurred in the Northeast (43.8%); these increases represent important changes in the geographic distribution of drug overdose deaths. Evidence-based prevention and response strategies including substance use disorder treatment and overdose prevention and response efforts focused on polysubstance use must be adapted to address the evolving drug overdose epidemic.
引用
- Mattson CL, Tanz LJ, Quinn K, et al. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33571180. doi:10.15585/mmwr.mm7006a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。